EPIX - Essa Pharma Inc
IEX Last Trade
5.52
0.030 0.543%
Share volume: 11,188
Last Updated: Fri 30 Aug 2024 09:00:39 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.49
0.03
0.55%
Fundamental analysis
27%
Profitability
27%
Dept financing
13%
Liquidity
50%
Performance
25%
Performance
5 Days
7.29%
1 Month
10.69%
3 Months
-15.94%
6 Months
-36.48%
1 Year
83.88%
2 Year
113.36%
Key data
Stock price
$5.52
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.58 - $11.67
52 WEEK CHANGE
$0.91
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: essapharma.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: essapharma.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.
Recent news